▼ -41.28% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Senseonics in the last 3 months. The average price target is $2.17, with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a -41.28% upside from the last price of $3.69.
The current consensus among 5 polled investment analysts is to hold stock in Senseonics. This Hold consensus rating has held steady for over two years.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.